Advanced Formulations and Therapies for Treating Hard-to-Heal Wounds

A wound healing composition, consisting of:

• from 2% to 15% by weight of a medicament characterized as a calcium channel blocker or pharmaceutically acceptable salts or solvates thereof;
• from 5% to 15% by weight of a medicament characterized as a hemorrheologic agent or pharmaceutically acceptable salts or solvates thereof;
• from 15% to 30% by weight of a dermal penetrating agent or pharmaceutically acceptable salts or solvates thereof;
• from 2% to 20% by weight of lecithin isopropyl palmitate;
• and
• wherein any remainder consists of a transdermal base.

A wound healing composition, consisting of:

• a medicament characterized as a calcium channel blocker or pharmaceutically acceptable salts or solvates thereof;
• a medicament characterized as a hemorrheologic agent or pharmaceutically acceptable salts or solvates thereof;
• a dermal penetrating agent or pharmaceutically acceptable salts or solvates thereof;
• lecithin isopropyl palmitate;
• and
• wherein any remainder consists of a transdermal base.

A wound healing composition, comprising:

• from 2% to 15% by weight of a medicament characterized as a calcium channel blocker or pharmaceutically acceptable salts or solvates thereof;
• from 5% to 15% by weight of a medicament characterized as a hemorrheologic agent or pharmaceutically acceptable salts or solvates thereof;
• from 15% to 30% by weight of a dermal penetrating agent or pharmaceutically acceptable salts or solvates thereof;
• from 2% to 20% by weight of lecithin isopropyl palmitate;
• and
• a transdermal base.